YALELAAN 62, 3584 CM UTRECHT, P7
Market cap: $6.8B (1/01/2026)
Price: $90.00
Acquisition Agreement with Genmab A/S for Common Shares at $97.00 Each
Merus N.V. Completes Acquisition of Common Shares from Genmab A/S
Merus N.V. Holds Extraordinary General Meeting for Shareholder Votes
To Acquire , Expanding Late-Stage Pipeline and Accelerating into a Wholly Owned Model
Material Contracts
Other Events
Shareholder votes
Q3
Q2
Q1
Amended Annual Report
FY 2024
Notice of Suspension of Duty to File Reports
Solicitation/Recommendation Statement
Tender Offer Statement by Third Party
Schedule 14D-9C Solicitation/Recommendation Statement Communication
Tender Offer Statement by Issuer
Prospectus filed pursuant to Rule 424(b)(5)
Definitive Merger Proxy Statement
Additional Proxy Materials
Definitive Proxy Statement
PRE 14A
Statement of Changes in Beneficial Ownership
Amended Schedule 13D - Ownership Report
Amended Notification Filed by a National Security Exchange
Schedule 13D - Ownership Report
Initial Statement of Beneficial Ownership
Amended Schedule 14D-9 Solicitation/Recommendation Statement
Amended Tender Offer Statement by Third Party
S-8 POS
Automatic Shelf Registration Statement